-
New Frontiers in Alzheimer’s
- Narrated by: Mack Sanderson, Kate Mulligan, Erica Sullivan, Traber Burns
- Length: 3 hrs and 26 mins
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
1 title per month from Audible’s entire catalog of best sellers, and new releases.
Access a growing selection of included Audible Originals, audiobooks and podcasts.
You will get an email reminder before your trial ends.
Your Premium Plus plan is $14.95 a month after 30 day trial. Cancel anytime.
Buy for $17.47
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
Publisher's Summary
Until recently, one idea has dominated research in treating Alzheimer’s disease: the amyloid hypothesis. Those therapies have repeatedly fallen short, and in this audiobook we take a look at where that hypothesis stands today. We examine recent research into the spectrum of disease causes, including inflammation and immune dysfunction; cutting-edge treatments, including deep-brain stimulation and magnetic resonance - guided focused ultrasound; as well as lifestyle interventions that can help protect from disease.
©2020 Scientific American, a division of Springer Nature America, Inc. (P)2021 Blackstone Publishing
More from the same
What listeners say about New Frontiers in Alzheimer’s
Average Customer RatingsOverall
Performance
Story